Verification evidence is still being completed.
PDF / print export
T-Knife
Berlin, Germany
- Verified lead
- Gabriele Eisner
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development
- Review cycle
- May 2026
- Full address
- Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official T-Knife contact page confirming the Berlin address.
- Editorial note
- T-Knife is published because official company materials confirm current leadership, Berlin operating address, and a real TCR-T oncology platform.
TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development
Official leadership disclosure, Official Berlin address disclosure, Cell-therapy platform claim
T-Knife is published because official company materials confirm current leadership, Berlin operating address, and a real TCR-T oncology platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Berlin, Germany
T-Knife
TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development · Clinical-stage cell-therapy platform
T-Knife runs tcr-t development, cell-therapy programs, and oncology platform development in Berlin, Germany.
- Lead
- Gabriele Eisner (verified ↗)
- Address
- Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Clinical-stage cell-therapy platform
- Capabilities
- TCR-T Development · Cell-Therapy Programs · Oncology Platform Development
- Founded
- 2018
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Gabriele Eisner
Chief Executive Officer
Full addressMax-Dohrn-Strasse 8-10, 10589 Berlin, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Clinical-stage cell-therapy platform
Berlin, Germany. TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development. Review completed on 22 Mar 2026.
German corporate and advanced-therapy oversight
Official leadership disclosure, Official Berlin address disclosure, Cell-therapy platform claim
TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development
T-Knife is published because official company materials confirm current leadership, Berlin operating address, and a real TCR-T oncology platform.
Editorial note
T-Knife is published because official company materials confirm current leadership, Berlin operating address, and a real TCR-T oncology platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
TCR-T Development
Cell-Therapy Programs
Oncology Platform Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
T-cell engineering workflow
Cell-therapy program systems
Oncology R&D infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is T-Knife located?
- T-Knife operates from Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany, Berlin, Germany.
- Who runs T-Knife?
- T-Knife is led by Gabriele Eisner, Chief Executive Officer. Verified 22 Mar 2026.
- What does T-Knife do?
- T-Knife runs tcr-t development, cell-therapy programs, and oncology platform development in Berlin, Germany. Core capabilities: TCR-T Development, Cell-Therapy Programs, Oncology Platform Development.
Editorial context
Related technical briefs
Briefs that name Berlin as a covered market or city.